Physician profile
Gregory C Pomeroy
NPI 1053313395
$51,629.43
in general payments reported to CMS, 2019-2025
12 companies · $11K in 2025
The $11K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $6,461 · 2021: $4,298 · 2022: $4,602 · 2023: $8,396 · 2024: $5,546 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $14K · Consulting Fee: $11K · Food and Beverage: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $13,850.29 |
| Consulting Fee | $10,556.00 |
| Food and Beverage | $174.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osteomed LLC | $26,064.77 | 2019-2022 | |
| Acumed LLC | $13,850.29 | 2023-2024 | Osteomed |
| Djo, LLC | $10,740.70 | 2019-2025 | Cmf |
| Medartis INC. | $261.89 | 2022-2023 | Aptus |
| Nextremity Solutions INC. | $208.68 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $116.85 | 2021 | |
| Paragon 28, INC. | $110.44 | 2019 | |
| Medical Device Business Services, INC. | $81.15 | 2019 | |
| Depuy Synthes Sales INC. | $67.23 | 2020 | |
| Zimmer Biomet Holdings, INC. | $64.79 | 2021 | |
| Medline Industries Lp | $51.12 | 2024 | |
| Orthofix Medical, INC. | $11.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Pomeroy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.